Clover Health director sells 67K shares
Clover Health Investments director Carladenise Armbrister Edwards reported an open-market sale of 67,160 shares of Class A Common Stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Clover Health Investments director Carladenise Armbrister Edwards reported an open-market sale of 67,160 shares of Class A Common Stock. The weighted average sale price was about $3.42 per share, with individual trades between $3.41 and $3.43. Following the sale, she directly holds 285,432 shares.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Class A Common Stock | 67,160 | $3.42 | $230K |
Footnotes (1)
- F1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.41 to $3.43, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price.
Key Figures
Key Terms
Class A Common Stock financial
open-market sale financial
weighted average price financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did director Carladenise Edwards do in this Clover Health (CLOV) Form 4?
Was the Clover Health (CLOV) insider sale executed in a single trade or multiple trades?
AI-generated analysis. How Rhea-AI works. Not financial advice.